title: Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study.
abstract: OBJECTIVE
  To substantially increase awareness, treatment and effective control of the metabolic syndrome (MetS) and its components.
  
  
  METHODS
  This is a pilot best practice implementation enhancement programme to reduce the estimated cardiovascular disease (CVD) risk in 628 MetS patients with or without diabetes or CVD by improving quality of care. A baseline visit was followed by action to improve adherence to lifestyle advice and drug treatment for CVD risk factors by physicians specifically trained to implement guidelines. Finally, after 6 months, a single-page form was completed, showing if patients were at CVD risk factor target. If not, there was an analysis of the reason why.
  
  
  RESULTS
  The programme was effective in improving utilization of evidence-based treatment in 628 MetS patients. There was a substantially greater patient perception of MetS, an enhancement in compliance with lifestyle advice and increased prescription of evidence-based medication, leading to a 48% (p < 0.0001) improvement in estimated CVD risk. There was a substantial increase in the number of subjects on target for specific CVD risk factors.
  
  
  CONCLUSIONS
  This is the first study to increase adherence to multiple interventions for all MetS components on an outpatient basis, in both primary care and teaching hospital settings. Physician and patient education, distribution of printed guidelines and brochures, and completion of a single-page form motivated both physicians and patients to achieve multiple CVD risk factor guideline goals. The absence of a control group is a limitation of this study. Further work is also needed to establish if the improvements observed are sustained on a long-term basis.
authors.affiliation: Atherosclerosis and Metabolic Syndrome Units, 2nd Propedeutic Department of Internal Medicine, Aristotelian University, Hippocration Hospital, Thessaloniki, Greece.
authors.forename: V G
authors.initials: VG
authors.lastname: Athyros
authors.forename: A
authors.initials: A
authors.lastname: Karagiannis
authors.forename: A I
authors.initials: AI
authors.lastname: Hatzitolios
authors.forename: K
authors.initials: K
authors.lastname: Paletas
authors.forename: C
authors.initials: C
authors.lastname: Savopoulos
authors.forename: G
authors.initials: G
authors.lastname: Giannoglou
authors.forename: D P
authors.initials: DP
authors.lastname: Mikhailidis
mesh_terms: D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000517:prevention & control*; D004282:Documentation / Q000592:standards; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000628:therapy; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000628:therapy*; D008875:Middle Aged; D009765:Obesity / Q000628:therapy; D010865:Pilot Projects; D017410:Practice Guidelines as Topic; D011322:Primary Prevention; D012307:Risk Factors; D040242:Risk Reduction Behavior; D011795:Surveys and Questionnaires